论文部分内容阅读
目的:为评价浙江省11家医院肺癌患者使用静脉营养制剂的应用状况,对其近5年的用药数据进行分析。方法:抽取浙江省11家医院2009~2013年肺癌患者每年40 d静脉营养制剂的用药医嘱,分析其使用静脉营养制剂用药金额、用药频度(DDDs)、DDC等情况。结果:5年来,该11家医院肺癌患者使用静脉营养制剂的用药总金额呈逐年上升趋势,尤其是2012年和2013年,增长速度很快,年增长百分比均达100%以上。其中占主要因素的是静脉脂肪乳剂金额的大幅增长,而2010~2012年氨基酸类静脉营养制剂使用金额的增幅不显著,2013年用药金额增加。结论:浙江省临床医生对于肺癌患者营养风险的重视程度越来越高,静脉营养制剂特别是特殊营养素呈现持续快速增长趋势,其在临床的合理化应用也有待进一步加强。
Objective: To evaluate the application status of intravenous nutrition in patients with lung cancer in 11 hospitals in Zhejiang Province and analyze the data of drug use in recent 5 years. Methods: The medical prescriptions of intravenous nutrition preparations for lung cancer patients at 40 days per year from 2009 to 2013 in 11 hospitals of Zhejiang Province were collected, and the dosage of intravenous nutritional drugs, DDDs and DDC were analyzed. Results: In the past five years, the total amount of intravenous nutritional drugs used in patients with lung cancer in the 11 hospitals has been increasing year by year. Especially in 2012 and 2013, the growth rate is very fast with a percentage annual increase of more than 100%. Which is the main factor is the substantial increase in the amount of intravenous fat emulsion, and the use of amino acid intravenous nutritional supplements in 2010 and 2012, the amount of increase was not significant, the amount of medication in 2013 increased. CONCLUSION: Zhejiang clinicians pay more and more attention to the nutrition risk of patients with lung cancer. The intravenous nutritional agents, especially special nutrients, show a sustained and rapid growth trend, and their clinical rationalization needs to be further strengthened.